These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14871449)

  • 1. Sensory manifestations in Charcot-Marie-Tooth disease.
    Gemignani F; Melli G; Alfieri S; Inglese C; Marbini A
    J Peripher Nerv Syst; 2004 Mar; 9(1):7-14. PubMed ID: 14871449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CMT1A and CMT2: similarities and differences.
    Bienfait HM; Verhamme C; van Schaik IN; Koelman JH; de Visser BW; de Haan RJ; Baas F; van Engelen BG; de Visser M
    J Neurol; 2006 Dec; 253(12):1572-80. PubMed ID: 16941080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gait patterns and functional measures between Charcot-Marie-Tooth disease type I and II in children to young adults.
    Pogemiller K; Garibay E; Pierz K; Acsadi G; Õunpuu S
    Gait Posture; 2020 Mar; 77():236-242. PubMed ID: 32062403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A.
    Lupski JR; Garcia CA
    Brain Pathol; 1992 Oct; 2(4):337-49. PubMed ID: 1341967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.
    Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T
    Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.
    Pareyson D; Scaioli V; Laurà M
    Neuromolecular Med; 2006; 8(1-2):3-22. PubMed ID: 16775364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2.
    Gemignani F; Marbini A
    J Neurol Sci; 2001 Feb; 184(1):1-9. PubMed ID: 11231025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
    Tazir M; Hamadouche T; Nouioua S; Mathis S; Vallat JM
    J Neurol Sci; 2014 Dec; 347(1-2):14-22. PubMed ID: 25454638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of sensory function in Charcot-Marie-Tooth disease.
    Ericson U; Borg K
    Acta Neurol Scand; 1999 May; 99(5):291-6. PubMed ID: 10348158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
    Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
    Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity.
    Lus G; Nelis E; Jordanova A; Löfgren A; Cavallaro T; Ammendola A; Melone MA; Rizzuto N; Timmerman V; Cotrufo R; De Jonghe P
    Neurology; 2003 Oct; 61(7):988-90. PubMed ID: 14557576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset autosomal dominant Charcot-Marie-Tooth 2 neuropathy in a Costa Rican family.
    Berghoff C; Berghoff M; Leal A; Morera B; Contreras C; Barrantes R; Rautenstrauss B; Del Valle G; Heuss D
    Neurol Res; 2009 Apr; 31(3):283-8. PubMed ID: 18826755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of somatosensory and muscular deficits on postural stabilization: Insights from an instrumented analysis of subjects affected by different types of Charcot-Marie-Tooth disease.
    Lencioni T; Piscosquito G; Rabuffetti M; Bovi G; Calabrese D; Aiello A; Di Sipio E; Padua L; Diverio M; Pareyson D; Ferrarin M
    Neuromuscul Disord; 2015 Aug; 25(8):640-5. PubMed ID: 26028275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies.
    Lawson VH; Gordon Smith A; Bromberg MB
    Exp Neurol; 2003 Dec; 184(2):753-7. PubMed ID: 14769367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic heterogeneity of Charcot-Marie-Tooth disease.
    Hentati A; Lamy C; Melki J; Zuber M; Munnich A; de Recondo J
    Genomics; 1992 Jan; 12(1):155-7. PubMed ID: 1733853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease.
    Kessali M; Zemmouri R; Guilbot A; Maisonobe T; Brice A; LeGuern E; Grid D
    Neurology; 1997 Apr; 48(4):867-73. PubMed ID: 9109869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.
    Luigetti M; Fabrizi GM; Bisogni G; Romano A; Taioli F; Ferrarini M; Bernardo D; Rossini PM; Sabatelli M
    Clin Neurol Neurosurg; 2016 May; 144():67-71. PubMed ID: 26989944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.